ArticleCancer research and treatment2022

The Feasibility of Using Biomarkers Derived from Circulating Tumor DNA Sequencing as Predictive Classifiers in Patients with Small-Cell Lung Cancer.

Yu Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.